Clinical trial
The Efficacy and Safety of Mycophenolate Mofetil in the Treatment of Lymphocytic Myocarditis in Comparison With Azathioprine
NCT05237323 is registered in ClinicalTrials.gov with I.M. Sechenov First Moscow State Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Mycophenolate Mofetil in the Treatment of Lymphocytic Myocarditis in Comparison With Azathioprine
- Lead sponsor
- I.M. Sechenov First Moscow State Medical University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 1, 2020
- Completion date
- July 10, 2025
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiomyopathies, dilated cardiomyopathy, heart failure, lymphocytic myocarditis (disorder), sudden cardiac death